| scholarly article | Q13442814 |
| P356 | DOI | 10.1097/01.CCM.0000063440.19188.ED |
| P698 | PubMed publication ID | 12794413 |
| P2093 | author name string | Alberto Merlini | |
| Aldo Luzzani | |||
| Alessio Rungatscher | |||
| Enrico Polati | |||
| Raffaella Pavan | |||
| Romolo Dorizzi | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | sepsis | Q183134 |
| P304 | page(s) | 1737-1741 | |
| P577 | publication date | 2003-06-01 | |
| P1433 | published in | Critical Care Medicine | Q5186605 |
| P1476 | title | Comparison of procalcitonin and C-reactive protein as markers of sepsis | |
| P478 | volume | 31 |
| Q28606587 | A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts |
| Q58282319 | A Pilot Study Assessing the Prognostic Value of CK18 and nDNA Biomarkers in Severe Sepsis Patients |
| Q34645087 | A composite score combining procalcitonin, C-reactive protein and temperature has a high positive predictive value for the diagnosis of intensive care-acquired infections |
| Q39751983 | A nurse-driven screening tool for the early identification of sepsis in an intermediate care unit setting |
| Q90256649 | A report of clinical diagnosis and treatment of nine cases of coronavirus disease 2019 |
| Q92097393 | A review of equine sepsis |
| Q35279631 | A study on biomarkers, cytokines, and growth factors in children with burn injuries. |
| Q36743345 | Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. |
| Q54222362 | Acute encephalopathy with biphasic seizures and late reduced diffusion associated with Streptococcus sanguinis sepsis. |
| Q38676048 | Altered levels of soluble CD18 may associate immune mechanisms with outcome in sepsis. |
| Q42025833 | Bacteraemia prediction in emergency medical admissions: role of C reactive protein |
| Q35136554 | Biomarkers as outcome predictors in subarachnoid hemorrhage--a systematic review |
| Q39252687 | Biomarkers for diagnosis of neonatal sepsis: a literature review |
| Q42835798 | Blood concentrations of lactate, C-reactive protein, and creatinine as early indicators of severity and outcome of sepsis |
| Q35919497 | C-Reactive Protein and Hemogram Parameters for the Non-Sepsis Systemic Inflammatory Response Syndrome and Sepsis: What Do They Mean? |
| Q43050412 | C-reactive protein is not a useful indicator for infection in surgical intensive care units |
| Q45065981 | C-reactive protein used as an early indicator of infection in patients with systemic inflammatory response syndrome |
| Q35966286 | CD64 and Group II Secretory Phospholipase A2 (sPLA2-IIA) as Biomarkers for Distinguishing Adult Sepsis and Bacterial Infections in the Emergency Department |
| Q40286673 | Can procalcitonin distinguish infectious fever from tumor-related fever in non-neutropenic cancer patients? |
| Q40274673 | Can serum procalcitonin and C-reactive protein as nosocomial infection markers in hospitalized patients without localizing signs? |
| Q34770031 | Changes in circulating procalcitonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients. |
| Q35741709 | Characteristics of neonates with culture-proven bloodstream infection who have low levels of C-reactive protein (≦10 mg/L) |
| Q35500737 | Characteristics of serum endocan levels in infection |
| Q49524910 | Clinical Utility and Measurement of Procalcitonin |
| Q92854598 | Clinical Value of Whole Blood Procalcitonin Using Point of Care Testing, Quick Sequential Organ Failure Assessment Score, C-Reactive Protein and Lactate in Emergency Department Patients with Suspected Infection |
| Q43174144 | Comparison between procalcitonin and C-reactive protein for early diagnosis of children with sepsis or septic shock |
| Q36513891 | Comparison of C-reactive protein and serum amyloid a protein in septic shock patients |
| Q41212841 | Comparison of procalcitonin and high-sensitivity C-reactive protein for the diagnosis of sepsis and septic shock in the oldest old patients |
| Q88921612 | Comparison of procalcitonin, C-reactive protein, white blood cell count and clinical status in diagnosing pneumonia in patients hospitalized with acute exacerbations of COPD: A prospective observational study |
| Q61450156 | Comparison of the accuracy of neutrophil CD64, procalcitonin, and C-reactive protein for sepsis identification: a systematic review and meta-analysis |
| Q94667718 | Coronavirus disease-2019 in cancer patients. A report of the first 25 cancer patients in a western country (Italy) |
| Q40281751 | Coupled Plasma Filtration Adsorption (CPFA) plus Continuous Veno-Venous Haemofiltration (CVVH) versus CVVH alone as an adjunctive therapy in the treatment of sepsis |
| Q37347840 | Coupled Plasma Filtration and Adsorption (CPFA): A Single Center Experience |
| Q87375421 | Delta mean neutrophil volume (ΔMNV) is comparable to procalcitonin for predicting postsurgical bacterial infection |
| Q87695828 | Determination of Factors Affecting Mortality of Patients with Sepsis in a Tertiary Intensive Care Unit |
| Q34446774 | Diagnosing external ventricular drain-related ventriculitis by means of local inflammatory response: soluble triggering receptor expressed on myeloid cells-1. |
| Q98471321 | Diagnosis and mortality prediction of sepsis via lysophosphatidylcholine 16:0 measured by MALDI-TOF MS |
| Q38086336 | Diagnostic and prognostic markers in sepsis |
| Q36553526 | Diagnostic markers of sepsis in the emergency department |
| Q98291171 | Diagnostic utility of procalcitonin as a biomarker for late-onset neonatal sepsis |
| Q21195047 | Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature |
| Q36088502 | Dynamics of C-reactive protein and white blood cell count in critically ill patients with nosocomial Gram positive vs. Gram negative bacteremia: a historical cohort study |
| Q36295952 | Early and innovative interventions for severe sepsis and septic shock: taking advantage of a window of opportunity |
| Q34999486 | Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study. |
| Q99349241 | Effect of a novel extracorporeal cytokine apheresis method on endocan, copeptin And interleukin-6 levels in sepsis: An observational prospective study |
| Q89793152 | Effect of neutrophil CD64 for diagnosing sepsis in emergency department |
| Q88093177 | Effects and cost of glycyrrhizin in the treatment of upper respiratory tract infections in members of the Japanese maritime self-defense force: Preliminary report of a prospective, randomized, double-blind, controlled, parallel-group, alternate-day |
| Q35159604 | Effects of fentanyl, midazolam and their combination on immune function and mortality in mice with sepsis |
| Q48676741 | Effects of single dose of dexamethasone on patients with systemic inflammatory response |
| Q35041641 | Efficacy of measuring procalcitonin levels in determination of prognosis and early diagnosis of bacterial resistance in sepsis |
| Q36749144 | Eosinopenia is a reliable marker of sepsis on admission to medical intensive care units. |
| Q44538842 | Evaluation of neutrophil CD64 expression and procalcitonin as useful markers in early diagnosis of sepsis |
| Q55317102 | Geriatric influenza death (GID) score: a new tool for predicting mortality in older people with influenza in the emergency department. |
| Q90237032 | High sPLA2-IIA level is associated with eicosanoid metabolism in patients with bacterial sepsis syndrome |
| Q35742583 | Identification of Predictive Early Biomarkers for Sterile-SIRS after Cardiovascular Surgery |
| Q33724228 | Identification of potential biomarkers of sepsis using bioinformatics analysis |
| Q33389518 | Impact of previous sepsis on the accuracy of procalcitonin for the early diagnosis of blood stream infection in critically ill patients |
| Q36099375 | Improved diagnostic approaches to infection/sepsis detection |
| Q40156133 | In vivo demonstration of neuroinflammatory molecule expression in brain abscess with diffusion tensor imaging |
| Q42857128 | Increased FGF21 plasma levels in humans with sepsis and SIRS. |
| Q41894720 | Interrelationship between procalcitonin and organ failure in sepsis |
| Q35805681 | Kinetics of Circulating Damage-Associated Molecular Patterns in Sepsis |
| Q24802598 | Measurements in the intensive care unit: what do they mean? |
| Q38045406 | Metabolic and toxicological considerations for sepsis drug treatments. |
| Q43097129 | Neutrophil gelatinase-associated lipocalin in adult septic patients with and without acute kidney injury |
| Q33996484 | Out-of-hospital characteristics and care of patients with severe sepsis: a cohort study |
| Q34558563 | Pentraxin 3 (PTX3) is associated with severe sepsis and fatal disease in emergency room patients with suspected infection: a prospective cohort study |
| Q42670100 | Pentraxin-3 to better delineate necrotizing soft tissue infection: not really! |
| Q38015927 | Persistent systemic inflammation in chronic critical illness |
| Q93148694 | Predictive value of procalcitonin for infection of patients with type-2 diabetes mellitus |
| Q79680732 | Procalcitonin and C-reactive protein as markers of systemic inflammatory response syndrome severity in critically ill children |
| Q34325775 | Procalcitonin as a diagnostic marker for sepsis: a systematic review and meta-analysis |
| Q35584452 | Procalcitonin for the differential diagnosis of infectious and non-infectious systemic inflammatory response syndrome after cardiac surgery |
| Q81516583 | Procalcitonin in preoperative diagnosis of abdominal sepsis |
| Q47812804 | Procalcitonin in severe acute respiratory syndrome (SARS). |
| Q36582374 | Procalcitonin kinetics - prognostic and diagnostic significance in septic patients |
| Q43777092 | Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia |
| Q57554486 | Procalcitonin kinetics in the prognosis of severe community-acquired pneumonia |
| Q40044544 | Procalcitonin level as a surrogate for catheter-related blood stream infection among hemodialysis patients |
| Q40695023 | Procalcitonin ratio and on-demand relaparotomy for septic peritonitis: validation of the focus index (FI). |
| Q95486819 | Procalcitonin to guide antibiotic stewardship in intensive care |
| Q41692073 | Procalcitonin versus C-reactive protein: Usefulness as biomarker of sepsis in ICU patient |
| Q26798459 | Procalcitonin-guided antibiotic therapy for septic patients in the surgical intensive care unit |
| Q38544528 | Procalcitonin: present and future |
| Q34500700 | Prognostic and diagnostic value of eosinopenia, C-reactive protein, procalcitonin, and circulating cell-free DNA in critically ill patients admitted with suspicion of sepsis |
| Q41893491 | Prognostic value of serum procalcitonin and C-reactive protein levels in critically ill patients who developed ventilator-associated pneumonia. |
| Q82456029 | Quantitative analysis of procalcitonin after pediatric cardiothoracic surgery |
| Q41672753 | Relationship between blood lactic acid, blood procalcitonin, C-reactive protein and neonatal sepsis and corresponding prognostic significance in sick children |
| Q37416933 | Risk prediction with procalcitonin and clinical rules in community-acquired pneumonia |
| Q58768597 | Role of C-reactive protein and procalcitonin in discriminating between infectious fever and tumor fever in non-neutropenic lung cancer patients |
| Q34802186 | Sensitivity and specificity of procalcitonin in predicting bacterial infections in patients with renal impairment |
| Q39386095 | Sepsis biomarkers in neutropaenic systemic inflammatory response syndrome patients on standard care wards |
| Q37689825 | Sepsis biomarkers: a review |
| Q36995847 | Sepsis: a clinical update. |
| Q34327126 | Septic encephalopathy |
| Q61449336 | Septic patients presenting with apparently normal C-reactive protein: A point of caution for the ER physician |
| Q36936715 | Serum C-reactive protein and procalcitonin levels in non-small cell lung cancer patients |
| Q45250123 | Serum C-reactive protein as a marker of outcome and infection in critical care patients |
| Q40146400 | Serum Level of HMGB1 Protein and Inflammatory Markers in Patients with Secondary Peritonitis: Time Course and the Association with Clinical Status |
| Q33325779 | Serum procalcitonin elevation in critically ill patients at the onset of bacteremia caused by either Gram negative or Gram positive bacteria |
| Q37615793 | Serum soluble triggering receptor expressed on myeloid cells-1 and procalcitonin can reflect sepsis severity and predict prognosis: a prospective cohort study |
| Q36336058 | Soluble membrane receptors, interleukin 6, procalcitonin and C reactive protein as prognostic markers in patients with severe sepsis and septic shock. |
| Q36020055 | The Clinical Challenge of Sepsis Identification and Monitoring |
| Q35107094 | The Japanese guidelines for the management of sepsis |
| Q58009551 | The Mortality in Emergency Department Sepsis Score as a Predictor of 1-Month Mortality among Adult Patients with Sepsis: Weighing the Evidence |
| Q38390462 | The intensive care infection score - a novel marker for the prediction of infection and its severity |
| Q44996293 | The last 100 years of sepsis |
| Q40185467 | The prognostic value of procalcitonin, C-reactive protein and cholesterol in patients with an infection and multiple organ dysfunction. |
| Q36714294 | The value of sepsis definitions in daily ICU-practice |
| Q64097459 | The value of the neutrophil-lymphocyte count ratio in the diagnosis of sepsis in patients admitted to the Intensive Care Unit: A retrospective cohort study |
| Q33320335 | Toward an operative diagnosis in sepsis: a latent class approach. |
| Q28078523 | Urosepsis--Etiology, Diagnosis, and Treatment |
| Q36768671 | Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis |
| Q37207285 | Useulness of B Natriuretic Peptides and Procalcitonin in Emergency Medicine. |
| Q34635570 | Utility of procalcitonin as an early diagnostic marker of bacteremia in patients with acute fever |
| Q35070651 | Utility of sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients |
| Q58596438 | Valuable prognostic indicators for severe burn sepsis with inhalation lesion: age, platelet count, and procalcitonin |
| Q92863246 | Value of dynamic plasma cell-free DNA monitoring in septic shock syndrome: A case report |
| Q36815796 | Value of serum procalcitonin in evaluating the prognosis of sepsis in elderly patients with colorectal cancer undergoing emergency colorectal surgery |
| Q36482805 | Variation of Circulating Inflammatory Mediators in Staphylococcus aureus and Escherichia coli Bloodstream Infection. |
| Q82077192 | [Procalcitonin plasma levels do not alter after uncomplicated skull base surgery] |
Search more.